These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 27399110

  • 1. Complete remission of thrombotic microangiopathy after treatment with eculizumab in a patient with non-Shiga toxin-associated bacterial enteritis: A case report.
    Omura T, Watanabe E, Otsuka Y, Yoshida Y, Kato H, Nangaku M, Miyata T, Oda S.
    Medicine (Baltimore); 2016 Jul; 95(27):e4104. PubMed ID: 27399110
    [Abstract] [Full Text] [Related]

  • 2. Atypical Hemolytic Uremic Syndrome With the p.Ile1157Thr C3 Mutation Successfully Treated With Plasma Exchange and Eculizumab: A Case Report.
    Saito D, Watanabe E, Ashida A, Kato H, Yoshida Y, Nangaku M, Ohtsuka Y, Miyata T, Hattori N, Oda S.
    Crit Care Explor; 2019 Apr; 1(4):e0008. PubMed ID: 32166254
    [Abstract] [Full Text] [Related]

  • 3. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
    Abe T, Sasaki A, Ueda T, Miyakawa Y, Ochiai H.
    Medicine (Baltimore); 2017 Feb; 96(6):e6056. PubMed ID: 28178155
    [Abstract] [Full Text] [Related]

  • 4. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M.
    J Med Case Rep; 2014 Sep 14; 8():307. PubMed ID: 25219386
    [Abstract] [Full Text] [Related]

  • 5. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
    Krishnappa V, Gupta M, Shah H, Das A, Tanphaichitr N, Novak R, Raina R.
    BMC Nephrol; 2018 Jan 12; 19(1):9. PubMed ID: 29329518
    [Abstract] [Full Text] [Related]

  • 6. [Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].
    Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K.
    Rinsho Ketsueki; 2018 Jan 12; 59(2):182-186. PubMed ID: 29515071
    [Abstract] [Full Text] [Related]

  • 7. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.
    Nephrology (Carlton); 2018 Jun 12; 23(6):507-517. PubMed ID: 29419916
    [Abstract] [Full Text] [Related]

  • 8. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.
    N Engl J Med; 2013 Jun 06; 368(23):2169-81. PubMed ID: 23738544
    [Abstract] [Full Text] [Related]

  • 9. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr 06; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 10. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI, Pôrto LC, Wagner T, Christiani LF, Palma LMP.
    Clin Rheumatol; 2017 Dec 06; 36(12):2859-2867. PubMed ID: 28905254
    [Abstract] [Full Text] [Related]

  • 11. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
    Ikeda T, Okumi M, Unagami K, Kanzawa T, Sawada A, Kawanishi K, Omoto K, Ishida H, Tanabe K.
    Nephrology (Carlton); 2016 Jul 06; 21 Suppl 1():35-40. PubMed ID: 26970541
    [Abstract] [Full Text] [Related]

  • 12. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB, Wazil AWM, Nanayakkara N, Samarakoon SMDK, Senavirathne EMSK, Thangarajah BUEWDR, Karunasena N, Mahanama RMBSS.
    J Med Case Rep; 2020 Jan 13; 14(1):11. PubMed ID: 31928535
    [Abstract] [Full Text] [Related]

  • 13. Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants.
    Ariceta G, Arrizabalaga B, Aguirre M, Morteruel E, Lopez-Trascasa M.
    Am J Kidney Dis; 2012 May 13; 59(5):707-10. PubMed ID: 22196848
    [Abstract] [Full Text] [Related]

  • 14. Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic Syndrome.
    Yamada Y, Abe R, Okano Y, Miyakawa Y.
    Intern Med; 2017 May 13; 56(9):1085-1088. PubMed ID: 28458317
    [Abstract] [Full Text] [Related]

  • 15. Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated by thrombotic microangiopathy with posterior reversible encephalopathy syndrome successfully treated with eculizumab: A case report.
    Kitamura F, Yamaguchi M, Nishimura M, Katsuno T, Ito M, Sugiyama H, Iwagaitsu S, Nobata H, Kinashi H, Ishimoto T, Banno S, Ito Y.
    Mod Rheumatol Case Rep; 2022 Jun 24; 6(2):254-259. PubMed ID: 35425980
    [Abstract] [Full Text] [Related]

  • 16. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
    Ono M, Ohashi N, Namikawa A, Katahashi N, Ishigaki S, Tsuji N, Isobe S, Iwakura T, Sakao Y, Tsuji T, Kato A, Fujigaki Y, Shimizu A, Yasuda H.
    Intern Med; 2018 Jun 01; 57(11):1617-1623. PubMed ID: 29434134
    [Abstract] [Full Text] [Related]

  • 17. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A.
    J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370
    [Abstract] [Full Text] [Related]

  • 18. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.
    Am J Kidney Dis; 2014 Jan 29; 63(1):40-8. PubMed ID: 24021908
    [Abstract] [Full Text] [Related]

  • 19. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].
    Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F.
    G Ital Nefrol; 2019 Apr 29; 36(2):. PubMed ID: 30983177
    [Abstract] [Full Text] [Related]

  • 20. Eculizumab in secondary atypical haemolytic uraemic syndrome.
    Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M.
    Nephrol Dial Transplant; 2017 Mar 01; 32(3):466-474. PubMed ID: 28339660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.